O’Shaughnessy’s front-page story about the FSMB jumps to include a long excerpt from an expose by journalist John Fauber naming the drug companies that gave FSMB millions to publicize their “model guidelines” re opioids. I suspect FSMB will get a big payoff for the “model guidelines” that constrain cannabis approvals. None of the marijuana reform groups in DC ever provide useful info or analysis to the clinicians.
On Apr 8, 2019, at 2:15 PM, Carmody, James B (Bryan) <James.Carmody@CHKD.ORG> wrote:No – but I appreciate any assistance you can provide in shining light on them. I’m trying to get people to think critically about these issues instead of accepting them unquestioningly._____________J. Bryan Carmody, MD, MPHThe Children’s Kidney CenterThe Children’s Hospital of the King’s Daughters601 Children’s LaneNorfolk, VA 23507(757) 668-7244From: Frederick Gardner [mailto:firstname.lastname@example.org]
Sent: Monday, April 08, 2019 4:30 PM
To: Carmody, James B (Bryan)
Subject: Re: Fan mail
External:Such a brazen liar (Chaudhry)! Have you written about the impact of the NBME’s profiteering (you put it much more diplomatically) on the content of the tests?Hopefully,Fred G.On Apr 8, 2019, at 6:23 AM, Carmody, James B (Bryan) wrote:You did – I just hadn’t looked at it closely till this morning. I hadn’t heard that Chaudhry story before… thank you for sharing!